144 related articles for article (PubMed ID: 26025668)
1. An AXIN2 Mutant Allele Associated With Predisposition to Colorectal Neoplasia Has Context-Dependent Effects on AXIN2 Protein Function.
Mazzoni SM; Petty EM; Stoffel EM; Fearon ER
Neoplasia; 2015 May; 17(5):463-72. PubMed ID: 26025668
[TBL] [Abstract][Full Text] [Related]
2. AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer.
Leclerc J; Beaumont M; Vibert R; Pinson S; Vermaut C; Flament C; Lovecchio T; Delattre L; Demay C; Coulet F; Guillerm E; Hamzaoui N; Benusiglio PR; Brahimi A; Cornelis F; Delhomelle H; Fert-Ferrer S; Fournier BPJ; Hovnanian A; Legrand C; Lortholary A; Malka D; Petit F; Saurin JC; Lejeune S; Colas C; Buisine MP
Genes Chromosomes Cancer; 2023 Apr; 62(4):210-222. PubMed ID: 36502525
[TBL] [Abstract][Full Text] [Related]
3. Esculetin suppresses tumor growth and metastasis by targeting Axin2/E-cadherin axis in colorectal cancer.
Kim WK; Byun WS; Chung HJ; Oh J; Park HJ; Choi JS; Lee SK
Biochem Pharmacol; 2018 Jun; 152():71-83. PubMed ID: 29534875
[TBL] [Abstract][Full Text] [Related]
4. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function.
Figeac N; Zammit PS
Cell Signal; 2015 Aug; 27(8):1652-65. PubMed ID: 25866367
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer.
Cheng LZ; Huang DL; Tang ZR; Zhang JH; Xiong T; Zhou C; Zhang NX; Fu R; Cheng YX; Wu ZQ
Br J Pharmacol; 2023 Dec; 180(23):3071-3091. PubMed ID: 37461816
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of a novel missense mutation in AXIN2 associated with non-syndromic tooth agenesis.
Yue H; Liang J; Yang K; Hua B; Bian Z
Eur J Oral Sci; 2016 Jun; 124(3):228-33. PubMed ID: 27090353
[TBL] [Abstract][Full Text] [Related]
8. Rare germline variants in the AXIN2 gene in families with colonic polyposis and colorectal cancer.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Walker R; Como J; Joo JE; Preston S; Hutchinson RA; Pope BJ; Metz A; Beard C; Purvis R; Arnold J; Vijay V; Konycheva G; Atkinson N; Parry S; Jenkins MA; Macrae FA; Rosty C; Winship IM; Buchanan DD
Fam Cancer; 2022 Oct; 21(4):399-413. PubMed ID: 34817745
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic confirmation of oligodontia, colorectal polyposis and cancer in a family carrying an exon 7 nonsense variant in the AXIN2 gene.
Beard C; Purvis R; Winship IM; Macrae FA; Buchanan DD
Fam Cancer; 2019 Jul; 18(3):311-315. PubMed ID: 30671715
[TBL] [Abstract][Full Text] [Related]
10. Co‑expression of Axin and APC gene fragments inhibits colorectal cancer cell growth via regulation of the Wnt signaling pathway.
Xu M; Liu X; Xu Y; Zhu S; Gao Y
Mol Med Rep; 2017 Oct; 16(4):3783-3790. PubMed ID: 28731177
[TBL] [Abstract][Full Text] [Related]
11. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.
Wu ZQ; Brabletz T; Fearon E; Willis AL; Hu CY; Li XY; Weiss SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11312-7. PubMed ID: 22745173
[TBL] [Abstract][Full Text] [Related]
12. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
13. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer.
Lammi L; Arte S; Somer M; Jarvinen H; Lahermo P; Thesleff I; Pirinen S; Nieminen P
Am J Hum Genet; 2004 May; 74(5):1043-50. PubMed ID: 15042511
[TBL] [Abstract][Full Text] [Related]
14. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
[TBL] [Abstract][Full Text] [Related]
15. AXIN1 and AXIN2 variants in gastrointestinal cancers.
Mazzoni SM; Fearon ER
Cancer Lett; 2014 Dec; 355(1):1-8. PubMed ID: 25236910
[TBL] [Abstract][Full Text] [Related]
16. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
17. Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines.
Suraweera N; Robinson J; Volikos E; Guenther T; Talbot I; Tomlinson I; Silver A
Int J Cancer; 2006 Oct; 119(8):1837-42. PubMed ID: 16708370
[TBL] [Abstract][Full Text] [Related]
18. AXIN2 Polymorphisms and Their Association with Colorectal Cancer in Mexican Patients.
Rosales-Reynoso MA; Arredondo-Valdez AR; Wence-Chávez LI; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
Genet Test Mol Biomarkers; 2016 Aug; 20(8):438-44. PubMed ID: 27228364
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic alterations of AXIN2 gene in adrenocortical tumors.
Chapman A; Durand J; Ouadi L; Bourdeau I
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1477-81. PubMed ID: 21733995
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
